Journal of Leukocyte Biology BioLegend: Treg, Th17, Stem Cell
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on March 1, 2008

Published online before print December 18, 2007
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0607349v1
83/3/648    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Battaglia, F.
Right arrow Articles by Bosco, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Battaglia, F.
Right arrow Articles by Bosco, M. C.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0607349


Received for publication May 29, 2007.
Revised November 13, 2007.
Accepted for publication November 14, 2007.


Article

Hypoxia transcriptionally induces macrophage-inflammatory protein-3{alpha}/CCL-20 in primary human mononuclear phagocytes through nuclear factor (NF)-{kappa}B

Florinda Battaglia *, Silvana Delfino *, Elisa Merello {dagger}, Maura Puppo *, Roberto Piva {ddagger}, Luigi Varesio *, and Maria Carla Bosco *@

Laboratories of *Molecular Biology and {dagger}Neurosurgery, G. Gaslini Institute, Genova, Italy; and {ddagger}Department of Pathology and Center for Experimental Research and Medical Studies (CeRMS), University of Turin, Torino, Italy

@ To whom correspondence should be addressed. E-mail: mcbosco1{at}virgilio.it.


   Abstract

Hypoxia, a condition of low oxygen tension, occurring in many pathological processes, modifies the mononuclear phagocyte transcriptional profile. Here, we demonstrate hypoxic up-regulation of the CCL20 chemokine in primary human monocytes (Mn) and macrophages. mRNA induction was paralleled by protein secretion and dependent on gene transcription activation. Functional studies of the CCL20 promoter using a series of 5`-deleted and mutated reporter constructs demonstrated the requirement for the NF-{kappa}B-binding site located at position –92/–82 for gene transactivation by hypoxia, as transcription was abrogated by a 3-bp mutation of the NF-{kappa}B motif; three copies of the wild-type NF-{kappa}B-binding site conferred hypoxia responsiveness to a minimal heterologous promoter; and hypoxia increased specific NF-{kappa}B binding to this sequence. Furthermore, we provide evidence of the specific role of a single NF-{kappa}B family member, p50, in mediating CCL20 gene transcription in hypoxic Mn. p50 homodimers were the only detectable NF-{kappa}B complexes binding the cognate {kappa}B site on the CCL20 promoter upon hypoxia exposure, and NF-{kappa}Bp50 knockdown by lentiviral-mediated short hairpin RNA interference resulted in complete binding inhibition. NF-{kappa}Bp50 overexpression in transient cotransfection studies promoted CCL20 gene transactivation, which was abrogated by mutation of the –92/–82 {kappa}B site. Moreover, nuclear expression of the other NF-{kappa}B family members was inhibited in hypoxic Mn. In conclusion, this study characterizes a previously unrecognized role for hypoxia as a transcriptional inducer of CCL20 in human mononuclear phagocytes and highlights the importance of the NF-{kappa}B pathway in mediating this response, with potential implications for inflammatory disease and cancer pathogenesis.

Key Words: monocytes • chemokines • gene regulation • transcription • inflammation




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
M. Puppo, F. Battaglia, C. Ottaviano, S. Delfino, D. Ribatti, L. Varesio, and M. C. Bosco
Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1{alpha} and -2{alpha}
Mol. Cancer Ther., July 1, 2008; 7(7): 1974 - 1984.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the Society for Leukocyte Biology.